This report details a locally advanced TNBC patient developing sequential grade 4 hepatotoxicity (ALT 1090 U/L), CTCAE grade 2 dermatitis, iPTH-driven hypercalcemia, and immune-mediated meningeal thickening following pembrolizumab chemotherapy. Here, GPT is linked to dermatitis.